Ashwanth Vidhya, Mumbai Uncensored, 1st July 2021:
America’s National Institute of Health has dismissed unsubstantiated rumors regarding the effectiveness of Covaxin, the vaccine which is produced and sold in India by Bharat Biotech, against the new variants of the coronavirus: alpha and delta. The governmental institution studied samples from those who received the vaccine and found out that it does indeed neutralise the different variants effectively ending the question of its effectiveness.
“The results from two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the U.K. and India, respectively,” they said.
The vaccine has already been administered to 25 million people in the country and the company plans to produce over 700 million doses by the end of this year.
How does the Covaxin Work?
The vaccine developed by Bharat Biotech and the Indian Council of Medical Research uses a form of the SARS- CoV-2 that can not replicate itself but at the same time be able to trigger the antibodies in our body. Adjuvant, a substance that is used to make the vaccines more effective, used in the vaccine is Alhydroxiquim-II which was developed in America by a biotech company called ViroVax LLC.
“Alhydroxiquim-II travels to lymph nodes, where the small molecule detaches from alum and activates two cellular receptors. These receptors, TLR7 and TLR8, play a vital role in the immune response to viruses. “Alhydroxiquim-II is the first adjuvant in an authorized vaccine against an infectious disease to activate TLR7 and TLR8. In addition, the alum in Alhydroxiquim-II stimulates the immune system to search for an invading pathogen.” Said the NIH in its press release about the functioning of the adjuvant. Phase 2 results reveal that the vaccine is safe and does not have drastic side-effects. Phase 3 results that have not been published yet do point to its effectiveness in protecting one from COVID.
